SynthesisNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology2014
Lack of association between UCHL1 S18Y gene polymorphism and Parkinson's disease in the Asian population: a meta-analysis.
Synthesis in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Parkinson's Disease in Saudi Patients: A Genetic Study.PloS one · 2015Trial
- Association study of DNAJC13, UCHL1, HTRA2, GIGYF2, and EIF4G1 with Parkinson's disease.Neurobiology of aging · 2021Article
- Mitochondrial Dysfunction in Parkinson's Disease.Experimental neurobiology · 2015Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Although many case-control studies have investigated the association between a single UCHL1 S18Y gene polymorphism and the risk of Parkinson's disease (PD), the results have been ambiguous. To evaluate the overall effect between published case-control studies of Asian subjects, we conducted a meta-analysis based on 11 studies including 3,971 PD cases and 3,721 controls. Studies carried out up to 30 April 2014, were identified using the databases PubMed, MEDLINE, EMBASE and Web of Knowledge. The crude odds ratios (ORs) with 95 % confidence intervals (95 % CI) were calculated to evaluate the association. The results of our meta-analysis indicated that the UCHL1 S18Y gene polymorphism does not correlate with the risk of PD (allele model: OR 0.93, 95 % CI 0.84-1.02; dominant model: OR 0.94, 95 % CI 0.86-1.04; recessive model: OR 0.90, 95 % CI 0.77-1.06; homozygous model: OR 0.86, 95 % CI 0.71-1.04). A similar result was observed in subgroup analysis of ethnicity, age at onset, genotype methods, Hardy-Weinberg equilibrium, and source of controls. Thus, the current meta-analysis suggests no evidence for the association between the UCHL1 S18Y polymorphism and PD risk in the Asian population, especially in subgroups of ethnicity and age at onset. Further studies with larger population sizes are needed to confirm this result.
Indexed as
Identifiers
25354657What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.